http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1279412-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4922c2d8ef3b675ad38900b030b925c6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
filingDate 1968-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2033611d86dddce85e17fcde297e40f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16029d6793cc32c4f7d70690e8daf738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf7b3517bab8da6b4245dcb746545a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cf364e0df46d8f6e92620d165637766
publicationDate 1972-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1279412-A
titleOfInvention Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion
abstract 1279412 Medicines comprising carbamates HASSLE AB 9 June 1969 [11 June 1968] 27787/68 Heading A5B [Also in Division C2] Pharmaceutical compositions for decreasing gastric hydrochloric acid secretion in mammals comprise a carbamate of formula I: (in which R<SP>1</SP> is C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 2-8 alkoxyalkyl, or a radical of formula II: wherein A is C 1-4 alkylene, C 1-4 alkyleneoxy linked to the phenyl nucleus via the oxygen atom, or C 2-8 alkyleneoxyalkylene linked to the phenyl nucleus via a carbon atom, and each of R<SP>4</SP> and R<SP>5</SP> is H, OH, C 1-3 alkyl, C 2-3 alkenyl, C 1-3 alkoxy, C 2-3 alkenoxy, C 1-4 hydroxyalkyl, F, Cl, Br, NO 2 , CHO or NH 2 ; and R<SP>2</SP> is H, C 1-4 alkyl, C 2-4 alkenyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl, C 2-8 alkoxyalkyl, C 3-9 alkoxyalkoxyalkyl, or a radical -COR<SP>3</SP> wherein R<SP>3</SP> is C 1-4 alkyl, C 2-4 alkenyl, C 1-4 alkoxy, C 2-4 alkeneoxy, C 2-8 alkoxyalkoxy, C 3-9 alkoxyalkoxyalkyl, C 2-8 alkoxyalkyl, or a radical of formula III: wherein B is a valency bond or C 1-4 alkyleneoxy linked to the phenyl nucleus via a carbon atom) together with an anticholinergic compound. A list of specific anticholinergics is given. Compounds I can also be used alone for decreasing gastric hydrochloric acid secretion in mammals.
priorityDate 1968-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559374

Total number of triples: 37.